Skye Bioscience (SKYE.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov11

Skye Bioscience released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3215 (forecast USD -0.3137)

00:00

Skye Bioscience released FY2025 9 Months Earnings on November 10 After-Market EST, Actual Revenue: USD 0, Actual EPS: USD -0.7244

00:00

Nov3

Skye Bioscience to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast EPS USD -0.3137

00:05

Oct6

Skye Bioscience Receiving Buy Rating but Downgraded

20:31

Skye Bioscience's experimental obesity drug fails to meet primary goals in mid-stage study

11:08

Oct2

Ananda Ghosh Gives a Buy Rating to Skye Bioscience's Nimacimab

06:31

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -12.75 M, EPS -0.3215

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -17.62 M, EPS -0.4444

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -11.1 M, EPS -0.28

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More